Jump to content
bristoldrv

UPDATED: Merck's Keytruda combo wows again, acing PhIII overall survival goal for lung cancer early - Endpoints News

Recommended Posts

images?q=tbn:ANd9GcRBaDc_-jx6P-lk0qcyK3E
Endpoints News

UPDATED: Merck's Keytruda combo wows again, acing PhIII overall survival goal for lung cancer early
Endpoints News
Merck's shares moved steadily upwards on the news, jumping 6% by mid-morning with Roche stock skidding 3.7% and Bristol-Myers shares down 2.7% as investors placed their bets. “The fact that MRK hit in KN-189 already means Roche won't get that leg up ...

and more »

View the full article

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...


×